MCCULLOCH KEVIN (See Remarks) received a stock award from XERIS BIOPHARMA HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/3/2025ACC: 0001867096-25-000027
Officer· See Remarks
Since Mar 2026
+606.87K
Net shares
Net buyer
$278.2K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
685K acquired · 78.13K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−29.30K
Price / share
$3.56
Trade value
$104.31K
% of position
1.9%
1/31/2025
1.58M→1.55M
Common Stock
Direct
Shares
−48.83K
Price / share
$3.56
Trade value
$173.85K
% of position
3.2%
1/31/2025
1.55M→1.50M
Common Stock
Direct
Shares
+185K
Price / share
—
Trade value
—
% of position
12.3%
1/31/2025
1.50M→1.68M
Total
Net shares
+106.87K
Net value
-$278.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2025 | F · Tax Withholding | −29.30K | $3.56 | $104.31K | 1.9% | 1.58M | 1.55M |
| Common Stock Direct | 1/31/2025 | F · Tax Withholding | −48.83K | $3.56 | $173.85K | 3.2% | 1.55M | 1.50M |
| Common Stock Direct | 1/31/2025 | A · Award | +185K | — | — | 12.3% | 1.50M | 1.68M |
| Total | +106.87K | -$278.16K | ||||||
Derivative Transactions1
Stock Appreciation Right
Direct
Converts to
Common Stock
500K shares
Shares
+500K
Strike price
3.56
Held after
500K
Exercisable
—
1/31/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Appreciation Right Direct | Common Stock500K shares | 1/31/2025 | A · Award | +500K | 3.56 | — | 500K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned2K
Common Stock
IndirectShares owned25K
Total
27K indirect27K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2K | Indirect |
| Common Stock | 25K | Indirect |
| Total | 27K | 27K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported